The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Internal Neuromodulation-Global Market Insights and Sales Trends 2025
Synopsis
Neuromodulation is used to regulate functions of nervous system, such as therapeutic alteration, inhibition, stimulation, modification, and others. There are two types of neuromodulation external neuromodulation and internal neuromodulation. Internal neuromodulation block or repair neuron signals of pain from reaching the brain using electrical impulses. These devices reduce highest levels of pain for various chronic or refractory diseases. Its clinical significance in pain reduction and therapeutics has lead a wide acceptance in the North American region.
The global Internal Neuromodulation market size is expected to reach US$ 3542.4 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Internal Neuromodulation in various end use industries. The expanding demands from the Parkinsons Disease, Chronic Pain and Others,, are propelling Internal Neuromodulation market. Spinal Cord Stimulator, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Deep Brain Stimulator segment is estimated at % CAGR for the next seven-year period.
The driving factors of the internal neuromodulation market are rising prevalence of neurological disorders, increase in the aging population, strong product pipeline, expanded target applications and new indications, and investments and funds. Moreover, technological advancements present opportunities for growth of the market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Internal Neuromodulation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Internal Neuromodulation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Internal Neuromodulation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Internal Neuromodulation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Internal Neuromodulation covered in this report include Medtronic PLC, Abbott, Boston Scientific Corp., Cerbomed GMBH, Cyberonics, Biocontrol Medical, Depuy Synthes Companies, Enteromedics and Synapse Biomedical, etc.
The global Internal Neuromodulation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic PLC
Abbott
Boston Scientific Corp.
Cerbomed GMBH
Cyberonics
Biocontrol Medical
Depuy Synthes Companies
Enteromedics
Synapse Biomedical
Uroplasty
Greatbatch
Abbott Laboratories
Nevro Corporation
NeuroSigma
MicroTransponder
Neuronetics
LivaNova PLC
Bioventus Inc
NeuroPace Inc
Global Internal Neuromodulation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Internal Neuromodulation market, Segment by Type:
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Neuro Stimulator
Global Internal Neuromodulation market, by Application
Parkinsons Disease
Chronic Pain
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Internal Neuromodulation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Neuromodulation is used to regulate functions of nervous system, such as therapeutic alteration, inhibition, stimulation, modification, and others. There are two types of neuromodulation external neuromodulation and internal neuromodulation. Internal neuromodulation block or repair neuron signals of pain from reaching the brain using electrical impulses. These devices reduce highest levels of pain for various chronic or refractory diseases. Its clinical significance in pain reduction and therapeutics has lead a wide acceptance in the North American region.
The global Internal Neuromodulation market size is expected to reach US$ 3542.4 million by 2029, growing at a CAGR of 7.6% from 2023 to 2029. The market is mainly driven by the significant applications of Internal Neuromodulation in various end use industries. The expanding demands from the Parkinsons Disease, Chronic Pain and Others,, are propelling Internal Neuromodulation market. Spinal Cord Stimulator, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Deep Brain Stimulator segment is estimated at % CAGR for the next seven-year period.
The driving factors of the internal neuromodulation market are rising prevalence of neurological disorders, increase in the aging population, strong product pipeline, expanded target applications and new indications, and investments and funds. Moreover, technological advancements present opportunities for growth of the market.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Internal Neuromodulation, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Internal Neuromodulation market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Internal Neuromodulation market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Internal Neuromodulation sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Internal Neuromodulation covered in this report include Medtronic PLC, Abbott, Boston Scientific Corp., Cerbomed GMBH, Cyberonics, Biocontrol Medical, Depuy Synthes Companies, Enteromedics and Synapse Biomedical, etc.
The global Internal Neuromodulation market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Medtronic PLC
Abbott
Boston Scientific Corp.
Cerbomed GMBH
Cyberonics
Biocontrol Medical
Depuy Synthes Companies
Enteromedics
Synapse Biomedical
Uroplasty
Greatbatch
Abbott Laboratories
Nevro Corporation
NeuroSigma
MicroTransponder
Neuronetics
LivaNova PLC
Bioventus Inc
NeuroPace Inc
Global Internal Neuromodulation market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Internal Neuromodulation market, Segment by Type:
Spinal Cord Stimulator
Deep Brain Stimulator
Sacral Nerve Stimulator
Vagus Nerve Stimulator
Gastric Neuro Stimulator
Global Internal Neuromodulation market, by Application
Parkinsons Disease
Chronic Pain
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Internal Neuromodulation companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Internal Neuromodulation
1.1 Internal Neuromodulation Market Overview
1.1.1 Internal Neuromodulation Product Scope
1.1.2 Internal Neuromodulation Market Status and Outlook
1.2 Global Internal Neuromodulation Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Internal Neuromodulation Market Size by Region (2018-2029)
1.4 Global Internal Neuromodulation Historic Market Size by Region (2018-2023)
1.5 Global Internal Neuromodulation Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Internal Neuromodulation Market Size (2018-2029)
1.6.1 North America Internal Neuromodulation Market Size (2018-2029)
1.6.2 Europe Internal Neuromodulation Market Size (2018-2029)
1.6.3 Asia-Pacific Internal Neuromodulation Market Size (2018-2029)
1.6.4 Latin America Internal Neuromodulation Market Size (2018-2029)
1.6.5 Middle East & Africa Internal Neuromodulation Market Size (2018-2029)
2 Internal Neuromodulation Market by Type
2.1 Introduction
2.1.1 Spinal Cord Stimulator
2.1.2 Deep Brain Stimulator
2.1.3 Sacral Nerve Stimulator
2.1.4 Vagus Nerve Stimulator
2.1.5 Gastric Neuro Stimulator
2.2 Global Internal Neuromodulation Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Internal Neuromodulation Historic Market Size by Type (2018-2023)
2.2.2 Global Internal Neuromodulation Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Internal Neuromodulation Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Internal Neuromodulation Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Internal Neuromodulation Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Internal Neuromodulation Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Internal Neuromodulation Revenue Breakdown by Type (2018-2029)
3 Internal Neuromodulation Market Overview by Application
3.1 Introduction
3.1.1 Parkinsons Disease
3.1.2 Chronic Pain
3.1.3 Others
3.2 Global Internal Neuromodulation Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Internal Neuromodulation Historic Market Size by Application (2018-2023)
3.2.2 Global Internal Neuromodulation Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Internal Neuromodulation Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Internal Neuromodulation Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Internal Neuromodulation Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Internal Neuromodulation Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Internal Neuromodulation Revenue Breakdown by Application (2018-2029)
4 Internal Neuromodulation Competition Analysis by Players
4.1 Global Internal Neuromodulation Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Internal Neuromodulation as of 2022)
4.3 Date of Key Players Enter into Internal Neuromodulation Market
4.4 Global Top Players Internal Neuromodulation Headquarters and Area Served
4.5 Key Players Internal Neuromodulation Product Solution and Service
4.6 Competitive Status
4.6.1 Internal Neuromodulation Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Medtronic PLC
5.1.1 Medtronic PLC Profile
5.1.2 Medtronic PLC Main Business
5.1.3 Medtronic PLC Internal Neuromodulation Products, Services and Solutions
5.1.4 Medtronic PLC Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.1.5 Medtronic PLC Recent Developments
5.2 Abbott
5.2.1 Abbott Profile
5.2.2 Abbott Main Business
5.2.3 Abbott Internal Neuromodulation Products, Services and Solutions
5.2.4 Abbott Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.2.5 Abbott Recent Developments
5.3 Boston Scientific Corp.
5.3.1 Boston Scientific Corp. Profile
5.3.2 Boston Scientific Corp. Main Business
5.3.3 Boston Scientific Corp. Internal Neuromodulation Products, Services and Solutions
5.3.4 Boston Scientific Corp. Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.3.5 Cerbomed GMBH Recent Developments
5.4 Cerbomed GMBH
5.4.1 Cerbomed GMBH Profile
5.4.2 Cerbomed GMBH Main Business
5.4.3 Cerbomed GMBH Internal Neuromodulation Products, Services and Solutions
5.4.4 Cerbomed GMBH Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.4.5 Cerbomed GMBH Recent Developments
5.5 Cyberonics
5.5.1 Cyberonics Profile
5.5.2 Cyberonics Main Business
5.5.3 Cyberonics Internal Neuromodulation Products, Services and Solutions
5.5.4 Cyberonics Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.5.5 Cyberonics Recent Developments
5.6 Biocontrol Medical
5.6.1 Biocontrol Medical Profile
5.6.2 Biocontrol Medical Main Business
5.6.3 Biocontrol Medical Internal Neuromodulation Products, Services and Solutions
5.6.4 Biocontrol Medical Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.6.5 Biocontrol Medical Recent Developments
5.7 Depuy Synthes Companies
5.7.1 Depuy Synthes Companies Profile
5.7.2 Depuy Synthes Companies Main Business
5.7.3 Depuy Synthes Companies Internal Neuromodulation Products, Services and Solutions
5.7.4 Depuy Synthes Companies Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.7.5 Depuy Synthes Companies Recent Developments
5.8 Enteromedics
5.8.1 Enteromedics Profile
5.8.2 Enteromedics Main Business
5.8.3 Enteromedics Internal Neuromodulation Products, Services and Solutions
5.8.4 Enteromedics Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.8.5 Enteromedics Recent Developments
5.9 Synapse Biomedical
5.9.1 Synapse Biomedical Profile
5.9.2 Synapse Biomedical Main Business
5.9.3 Synapse Biomedical Internal Neuromodulation Products, Services and Solutions
5.9.4 Synapse Biomedical Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.9.5 Synapse Biomedical Recent Developments
5.10 Uroplasty
5.10.1 Uroplasty Profile
5.10.2 Uroplasty Main Business
5.10.3 Uroplasty Internal Neuromodulation Products, Services and Solutions
5.10.4 Uroplasty Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.10.5 Uroplasty Recent Developments
5.11 Greatbatch
5.11.1 Greatbatch Profile
5.11.2 Greatbatch Main Business
5.11.3 Greatbatch Internal Neuromodulation Products, Services and Solutions
5.11.4 Greatbatch Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.11.5 Greatbatch Recent Developments
5.12 Abbott Laboratories
5.12.1 Abbott Laboratories Profile
5.12.2 Abbott Laboratories Main Business
5.12.3 Abbott Laboratories Internal Neuromodulation Products, Services and Solutions
5.12.4 Abbott Laboratories Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.12.5 Abbott Laboratories Recent Developments
5.13 Nevro Corporation
5.13.1 Nevro Corporation Profile
5.13.2 Nevro Corporation Main Business
5.13.3 Nevro Corporation Internal Neuromodulation Products, Services and Solutions
5.13.4 Nevro Corporation Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.13.5 Nevro Corporation Recent Developments
5.14 NeuroSigma
5.14.1 NeuroSigma Profile
5.14.2 NeuroSigma Main Business
5.14.3 NeuroSigma Internal Neuromodulation Products, Services and Solutions
5.14.4 NeuroSigma Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.14.5 NeuroSigma Recent Developments
5.15 MicroTransponder
5.15.1 MicroTransponder Profile
5.15.2 MicroTransponder Main Business
5.15.3 MicroTransponder Internal Neuromodulation Products, Services and Solutions
5.15.4 MicroTransponder Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.15.5 MicroTransponder Recent Developments
5.16 Neuronetics
5.16.1 Neuronetics Profile
5.16.2 Neuronetics Main Business
5.16.3 Neuronetics Internal Neuromodulation Products, Services and Solutions
5.16.4 Neuronetics Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.16.5 Neuronetics Recent Developments
5.17 LivaNova PLC
5.17.1 LivaNova PLC Profile
5.17.2 LivaNova PLC Main Business
5.17.3 LivaNova PLC Internal Neuromodulation Products, Services and Solutions
5.17.4 LivaNova PLC Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.17.5 LivaNova PLC Recent Developments
5.18 Bioventus Inc
5.18.1 Bioventus Inc Profile
5.18.2 Bioventus Inc Main Business
5.18.3 Bioventus Inc Internal Neuromodulation Products, Services and Solutions
5.18.4 Bioventus Inc Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.18.5 Bioventus Inc Recent Developments
5.19 NeuroPace Inc
5.19.1 NeuroPace Inc Profile
5.19.2 NeuroPace Inc Main Business
5.19.3 NeuroPace Inc Internal Neuromodulation Products, Services and Solutions
5.19.4 NeuroPace Inc Internal Neuromodulation Revenue (US$ Million) & (2018-2023)
5.19.5 NeuroPace Inc Recent Developments
6 North America
6.1 North America Internal Neuromodulation Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Internal Neuromodulation Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Internal Neuromodulation Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Internal Neuromodulation Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Internal Neuromodulation Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Internal Neuromodulation Market Dynamics
11.1 Internal Neuromodulation Industry Trends
11.2 Internal Neuromodulation Market Drivers
11.3 Internal Neuromodulation Market Challenges
11.4 Internal Neuromodulation Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
